Honasa Consumer Ltd Q1 FY27 Earnings Analysis

Published 31 May 2026 | Personal Products | Market Cap: ₹11.5K Cr

Price

403

Market Cap

₹11.5K Cr

P/E Ratio

74.5

Revenue Rank

Rank 3

Margin Rank

Rank 1

Earnings Summary

- Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years. - Honasa plans a high-teens CAGR growth over the next 5 years. - The company aims to improve its EBITDA margin by 500 basis points over the same period. - Annual EBITDA expansion target is about 100 basis points per year. - Mamaearth is expected to grow at a double-digit CAGR over the next 5 years. - Younger brands are growing strongly, with growth rates near 40% including acquisitions. - The focus categories, receiving over 90% of investment, are expected to continue driving growth. - Margins for core brands like Mamaearth and Derma Co.

📊 Revenue & Sales Performance

Rank 3

- Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years. - Annual EBITDA margin improvement target is approximately 100 basis points per year, totaling a 500 basis points expansion over 5 years. - Young brands are expected to continue driving strong growth at high levels. - Focus categories receive over 90% of investment and are anticipated to be key growth drivers. - Mamaearth aims for a double-digit CAGR over the next 5 years, with potential to increase distribution from 200,000 to 0.5 million outlets. - The recently acquired Reginald Men brand has doubled revenue year-on-year and is expected to grow over the next 3-5 years through distribution, category expansion, and geographic growth. - The company emphasizes premiumization trends and plans to capitalize on consumer aspirations for differentiated, aspirational products.

📈 Profitability & Margins

Rank 1

- Honasa plans a high-teens CAGR growth over the next 5 years. - The company aims to improve its EBITDA margin by 500 basis points over the same period. - Annual EBITDA expansion target is about 100 basis points per year. - Mamaearth is expected to grow at a double-digit CAGR over the next 5 years. - Younger brands are growing strongly, with growth rates near 40% including acquisitions. - The focus categories, receiving over 90% of investment, are expected to continue driving growth. - Margins for core brands like Mamaearth and Derma Co. are currently double-digit EBITDA positive and expected to improve. - The company delivered a 20%+ Y-o-Y growth in FY'26 with EBITDA tripling and a 9.3% EBITDA margin. - Management is confident of delivering better than benchmark results in some years based on strategy and market conditions.

🏗️ Capital Expenditure Plans

Yes

- The company is focused on investing in talent, as evidenced by recent key appointments including a CEO with cosmetics and makeup experience, a nutraceutical founder, and other experts to build new businesses and shape future growth horizons. - Strategic investments are made in expanding distribution, especially for acquired brands like Reginald Men, where efforts to scale distribution across platforms like e-commerce channels (e.g., Nykaa) and new geographies (such as Maharashtra) are underway. - There is a focus on category expansion and innovation, investing in R&D and new product launches to enter new partitions and take structural market share. - Investments in brand building and content creation to support premiumization and aspirational branding are ongoing, backed by a combination of channel spend, brand spend, and operational expense management. - The company plans to continue deploying relevant inorganic opportunities while maintaining strong cash generation, enabling ongoing investments.

💰 Fundraising & Capital Structure

No information

The document does not mention any current or planned future fundraising through debt or equity. Key points: - No explicit discussion or announcement regarding raising debt or equity funds. - Focus remains on organic growth, improving EBITDA margins, and leveraging internal cash generation. - Company highlights strong cash generation capabilities, maintaining negative working capital. - Dividend payout of INR 3 per share (~50% of PAT) suggests confidence in cash flows without reliance on external funding. - Mention of inorganic opportunities funded from internal cash resources, indicating no immediate need for external fundraising. In summary, Honasa Consumer Limited currently does not indicate any plans for new fundraising via debt or equity in the near term.

📋 Order Book & Pipeline

Yes

The provided transcript of Honasa Consumer Limited's Q4 and FY26 earnings call does not specifically mention any details about the company's current or expected order book or pending orders. The discussion primarily focuses on: - Financial performance (revenue growth, EBITDA, PAT) - Brand growth and strategies (Mamaearth, Derma Co., Reginald Men) - Channel and category focus - Margin expansion and premiumization strategy - Marketing and distribution initiatives - Future growth outlook and CAGR expectations No explicit information regarding order book status or pending order details was disclosed in the call transcript.

Key Metrics

Revenue

Rank 3

Margin

Rank 1

Capex

Yes

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Honasa Consumer Ltd Q1 FY27 results?

- Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years. - Honasa plans a high-teens CAGR growth over the next 5 years. - The company aims to improve its EBITDA margin by 500 basis points over the same period. - Annual EBITDA expansion target is about 100 basis points per year. - Mamaearth is expected to grow at a double-digit CAGR over the next 5 years. - Younger brands are growing strongly, with growth rates near 40% including acquisitions. - The focus categories, receiving over 90% of investment, are expected to continue driving growth. - Margins for core brands like Mamaearth and Derma Co.

What is Honasa Consumer Ltd share price analysis?

Honasa Consumer Ltd currently shows a below-average growth signal. The stock trades at a P/E of 74.5 with a market cap of ₹11,518. Investors should review the full earnings analysis for detailed insights.

Is Honasa Consumer Ltd planning capital expenditure?

- The company is focused on investing in talent, as evidenced by recent key appointments including a CEO with cosmetics and makeup experience, a nutraceutical founder, and other experts to build new businesses and shape future growth horizons.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Personal Products this season

  • Bajaj Consumer Care Ltd (Q1 FY27)

    Bajaj Consumer Care Ltd Q1 FY27 quarterly results analysis. - The company aims for a double-digit volume growth in Almond Drop Hair Oil (ADHO), with Q4 volume g

  • Godrej Consumer Products Ltd (Q1 FY27)

    Godrej Consumer Products Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹106,33

  • Gillette India Ltd (Q1 FY27)

    Gillette India Ltd Q1 FY27 quarterly results analysis. - Gillette India anticipates balanced, sustained growth through its Integrated Growth Strategy. Market Ca

  • Procter & Gamble Hygiene and Health Care Ltd (Q1 FY27)

    Procter & Gamble Hygiene and Health Care Ltd Q1 FY27 quarterly results analysis. - The company expects balanced and sustained long-term growth, focusing on cons